← Browse by Condition
Medical Condition
peripheral vascular disease
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 3
ClinicalMetric tracks all active clinical trials for peripheral vascular disease sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 3 1
Top Sponsors
2 trials
1 trial
NCT07144150
Recruiting
EVERO Drug-coated Balloon (DCB) Randomized Trial
Enrollment
410 pts
Location
United States
Sponsor
Cook Research Incorporated
NCT06399900
Recruiting
ENhancing Exercise with LIGHT to Improve Functioning in PAD
Enrollment
32 pts
Location
United States
Sponsor
Northwestern University
NCT06686121 Phase 3
Recruiting
Improving Mobility After Revascularization in Peripheral Artery Disease
Enrollment
386 pts
Location
United States
Sponsor
Northwestern University
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology